Lincoln Pharma receives permission to manufacture HCQ
Lincoln Pharma receives permission to manufacture HCQ

Lincoln Pharma receives permission to manufacture HCQ

Anthony Fernandes Article rating: 5.0

One of the country’s leading healthcare companies, Lincoln Pharmaceuticals Limited, informed the bourses on Monday that it has received approval from Food & Drugs Control Administration (FDCA) Gujarat, to manufacture Hydroxychloroquine (HCQ), among other critical drugs to fight COVID-19.

Sensex climbs on RBIs support for MF
Sensex climbs on RBIs support for MF

Sensex climbs on RBIs support for MF

Geyatee Deshpande Article rating: 5.0

Sensex climbed by 415.86 points which is 1.333 per cent to be at the level of 31,743.08 while, Nifty rose by 127.90 points, which is 1.40 per cent to be at the level of 9,282.30 as RBI announced Rs 50,000 crore liquidity support for mutual funds. Post which, AMC stocks had gained by more than five per cent.

BEML bag orders worth Rs 398 crore from Coal India Ltd
BEML bag orders worth Rs 398 crore from Coal India Ltd

BEML bag orders worth Rs 398 crore from Coal India Ltd

Rishikesh Gaikwad Article rating: 4.0

BEML has bagged orders worth Rs 398 crore (inclusive of taxes) from  Coal India Limited (CIL), for the supply of seven 150-T dumpers and eight 190-T dumpers under the trial cum sale, along with a contract for spare parts for eight years on April 24, 2020.

Balkrishna Industries shine on resuming partial operation
Balkrishna Industries shine on resuming partial operation

Balkrishna Industries shine on resuming partial operation

Amir Shaikh Article rating: 1.7

Balkrishna Industries has partially resumed its manufacturing operations pursuant to the recent notifications and directives of the government and local authorities

Myth buster: SIP is superior to lumpsum investment
Myth buster: SIP is superior to lumpsum investment

Myth buster: SIP is superior to lumpsum investment

Henil Shah Article rating: 3.8

We all know that SIP is one of the most efficient ways of investing. However, is it wise to call it superior than lumpsum investment? We shall find it out in this article.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Abhishek Kapoor Article rating: 3.7

The market opened in the green on April 27, 2020. The previous trading session witnessed the Sensex going down by 1.68 percent to end at 31,327.22 and the Nifty was down 1.71 percent to close at 9,154.50.

Ten stocks close to their 52-week low
Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Abhishek Kapoor Article rating: 3.7

The market opened in the green on April 27, 2020. The previous trading session witnessed the Sensex going down by 1.68 percent to end at 31,327.22 and the Nifty was down 1.71 percent to close at 9,154.50.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Abhishek Kapoor Article rating: 4.8

The market opened in the green on April 27, 2020, overall volumes in futures & options currently stand at 1.19 crore contracts with a turnover of Rs. 6,37,107.29 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Abhishek Kapoor Article rating: 4.0

The market opened in the green on April 27, 2020, overall volumes in futures & options currently stand at 1.19 crore contracts with a turnover of Rs. 6,37,107.29 crore.

RSS
First22932294229522962298230023012302Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR